We are thrilled to announce the successful launch of Slenyto in South Korea on September 25th. This unique medication is set to make a significant impact, improving the lives of […]
We are excited to announce that Neurim Pharmaceuticals received a positive CHMP opinion on Slenyto® (Pediatric Prolonged-Release Melatonin) for the treatment of Insomnia in children with Neurogenetic Disorders (NGDs). This […]